SINGLE-USE BIOPROCESSING SYSTEMS MARKET ANALYSIS

Single-use Bioprocessing Systems Market, By Product Type (Bioreactors, Bags and Containers, Filtration Devices, Tubing Assemblies and Connectors, Sensors and Probes, Others), By Application (Monoclonal Antibody Production, Vaccine Production, Cell Therapy, Viral Vector Production, Gene Therapy, Other, Biopharmaceutical Production Processes), By End User (Biopharmaceutical Companies, CROs & CMOs, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Global Single-use Bioprocessing Systems Market- Recent Developments

Product Launch & Product Approval

On September 15, 2024, Getinge, one of the leading medtech companies, announced the launch of AppliFlex ST GMP, a single-use bioreactor system designed for clinical production in cell and gene therapy as well as mRNA production.
On May 2, 2024, DuPont, a chemical company, showcased DuPon Liveo single-use biopharma processing solutions for critical fluid transport applications at BioProcess International Europe, which was held on May 9-12, 2024.

Acquisition and Partnership

On May 31, 2024, Getinge announced an agreement to acquire 100% of the shares in High Purity New England, Inc., one of the leading U.S.-based companies in the area of custom single-use solutions for bioprocessing applications.
In December 2020, Pall Corporation, one of the global leaders in filtration, separation, and purification, announced a strategic partnership with Single Use Support GmbH, one of the leading providers and end-to-end solutions for safe handling of biologics, from bulk manufacturing to fill finishing to distribute, which protects single-use bags and contains drug substances during freezing, thawing, storage, and shipping.